Internal Medicine, Endocrinology, Diabetes, & Metabolism · Fayetteville, NC
NPI
1225285042
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
101 Robeson St Ste 405
Fayetteville, NC, 28301
Phone (910) 615-1623
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
1,000 services
Medicare patients, 2024
362
Average age 71
Drug cost, 2024
$5.1M
8,789 prescriptions
Company payments, 2025
$102
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anju Gurung was code 99214 (office e&m - established), 612 times for 319 patients. In total Anju Gurung billed 1,000 services in 11 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 612 | 319 | $62.73 | $38K |
| 95251 Test - Miscellaneous | Office | 268 | 129 | $23.55 | $6,312 |
| 99213 Office E&M - Established | Office | 39 | 32 | $47.16 | $1,839 |
| 99215 Office E&M - Established | Office | 31 | 29 | $87.94 | $2,726 |
| 99204 Office E&M - New | Office | 23 | 23 | $84.56 | $1,945 |
By year: 2022 $69K for 1,234 services; 2023 $61K for 1,136 services; 2024 $52K for 1,000 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anju Gurung prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,017 prescriptions and refills. In total Anju Gurung wrote 8,789 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,017 | 1,721 | 222 | $1.7M |
| Metformin Hcl Er Metformin Hcl | 552 | 1,325 | 165 | $5,007 |
| Levothyroxine Sodium Generic | 543 | 1,339 | 148 | $4,386 |
| Jardiance Empagliflozin | 497 | 986 | 119 | $578K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 485 | 1,291 | 172 | $68K |
| Metformin Hcl Generic | 382 | 895 | 107 | $2,302 |
| Janumet Xr Sitagliptin Phos/Metformin Hcl | 333 | 688 | 88 | $336K |
| Methimazole Generic | 217 | 518 | 59 | $1,557 |
| Mounjaro Tirzepatide | 212 | 309 | 53 | $337K |
| Novolog Flexpen Insulin Aspart | 208 | 456 | 81 | $74K |
| Trulicity Dulaglutide | 205 | 279 | 58 | $272K |
| Ondansetron Hcl Generic | 201 | 205 | 92 | $2,095 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 199 | 451 | 82 | $23K |
| Tresiba Flextouch U-100 Insulin Degludec | 175 | 433 | 62 | $128K |
| Acarbose Generic | 154 | 348 | 59 | $4,805 |
Brand drugs: 5,402 claims; generic drugs: 2,461 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anju Gurung $102 ($102 in general payments such as food, travel and fees) from 3 companies. The largest payer was Sequel Med Tech, LLC with $60.67.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.